Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

Garrett M. Frampton; Alex Fichtenholtz; Geoff Otto; Kai Wang; Sean R. Downing; Jie He; Michael Schnall-Levin; Jared White; Eric M. Sanford; Peter An; James Sun; Frank Juhn; Kristina Brennan; Kiel Iwanik; Ashley Maillet; Jamie Buell; Emily White; Mandy Zhao; Sohail Balasubramanian; Selmira Terzic; Tina Richards; Vera Banning; Lázaro Ibrahim Romero García; Kristen Mahoney; Zac Zwirko; Amy Donahue; Himisha Beltran; Juan Miguel Mosquera; Mark A. Rubin; Snjezana Doğan; Cyrus V. Hedvat; Michael F. Berger; Lajos Pusztai; Matthias Lechner; Chris Boshoff; Mirna Jarosz; Christine Vietz; Alex Parker; Vincent A. Miller; Jeffrey S. Ross; John A. Curran; Maureen Cronin; Philip J. Stephens; Doron Lipson; Roman Yelensky

doi:10.1038/nbt.2696

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

Garrett M. Frampton(Foundation Medicine (United States)), Alex Fichtenholtz(Foundation Medicine (United States)), Geoff Otto(Foundation Medicine (United States)), Kai Wang(Foundation Medicine (United States)), Sean R. Downing(Foundation Medicine (United States)), Jie He(Foundation Medicine (United States)), Michael Schnall-Levin(Foundation Medicine (United States)), Jared White(Foundation Medicine (United States)), Eric M. Sanford(Foundation Medicine (United States)), Peter An(Foundation Medicine (United States)), James Sun(Foundation Medicine (United States)), Frank Juhn(Foundation Medicine (United States)), Kristina Brennan(Foundation Medicine (United States)), Kiel Iwanik(Foundation Medicine (United States)), Ashley Maillet(Foundation Medicine (United States)), Jamie Buell(Foundation Medicine (United States)), Emily White(Foundation Medicine (United States)), Mandy Zhao(Foundation Medicine (United States)), Sohail Balasubramanian(Foundation Medicine (United States)), Selmira Terzic(Foundation Medicine (United States)), Tina Richards(Foundation Medicine (United States)), Vera Banning(Foundation Medicine (United States)), Lázaro Ibrahim Romero García(Foundation Medicine (United States)), Kristen Mahoney(Foundation Medicine (United States)), Zac Zwirko(Foundation Medicine (United States)), Amy Donahue(Foundation Medicine (United States)), Himisha Beltran(NewYork–Presbyterian Hospital), Juan Miguel Mosquera(New York Hospital Queens), Mark A. Rubin(New York Hospital Queens), Snjezana Doğan(Memorial Sloan Kettering Cancer Center), Cyrus V. Hedvat(Memorial Sloan Kettering Cancer Center), Michael F. Berger(Memorial Sloan Kettering Cancer Center), Lajos Pusztai(Yale Cancer Center), Matthias Lechner(University College London), Chris Boshoff(CRUK Lung Cancer Centre of Excellence), Mirna Jarosz(Foundation Medicine (United States)), Christine Vietz(Foundation Medicine (United States)), Alex Parker(Foundation Medicine (United States)), Vincent A. Miller(Foundation Medicine (United States)), Jeffrey S. Ross(Albany Medical Center Hospital), John A. Curran(Foundation Medicine (United States)), Maureen Cronin(Foundation Medicine (United States)), Philip J. Stephens(Foundation Medicine (United States)), Doron Lipson(Foundation Medicine (United States)), Roman Yelensky(Foundation Medicine (United States))

Nature Biotechnology

October 20, 2013

10.1038/nbt.2696

Cited by 2,186Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis